Trials / Completed
CompletedNCT02439736
EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY
A PROSPECTIVE CLINICAL EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (actual)
- Sponsor
- Banyan Biomarkers, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely with traumatic brain injury (Glasgow Coma Scale score 9-15).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw within 12 hours of head injury |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2015-05-12
- Last updated
- 2017-08-08
Locations
7 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT02439736. Inclusion in this directory is not an endorsement.